Effect of type 2 innate lymphocytes on Treg and CD8+ T cell function through IL-9 in chronic lymphocytic leukemia.
- Author:
Ruixue YANG
1
;
Xuejiao ZENG
2
;
Jianhua QU
3
,
4
Author Information
1. Center of Hematology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054; Hematology Institute of Xinjiang Uygur Autonomous Region, Urumqi 830054; Hematology Clinical Research Center of Xinjiang Uygur Autonomous Region, Urumqi 830054, China.
2. Center of Hematology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China.
3. Center of Hematology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054; Hematology Institute of Xinjiang Uygur Autonomous Region, Urumqi 830054; Hematology Clinical Research Center of Xinjiang Uygur Autonomous Region, Urumqi 830054, China. *Corresponding author, E-mail: jhuaqu@
4. com.
- Publication Type:Journal Article
- MeSH:
Humans;
Leukemia, Lymphocytic, Chronic, B-Cell/immunology*;
CD8-Positive T-Lymphocytes/immunology*;
T-Lymphocytes, Regulatory/immunology*;
Middle Aged;
Male;
Female;
Interleukin-9/blood*;
Aged;
Granzymes/metabolism*;
Perforin/metabolism*;
Immunity, Innate;
Adult;
Lymphocytes/immunology*
- From:
Chinese Journal of Cellular and Molecular Immunology
2025;41(8):673-679
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the differences of type 2 innate lymphocytes (ILC2) and interlukin 9 (IL-9) between chronic lymphocytic leukemia (CLL) patients and healthy controls, and to understand the effects of ILC2 on the function of regulatory T cells (Tregs), CD8+ T cells and CLL cells through IL-9. Methods Flow cytometry was used to detect the levels of ILC2 and Tregs in the peripheral blood of 45 newly diagnosed CLL patients and 24 healthy controls, and the expressions of granzyme B and perforin in CD8+ T cells in the peripheral blood of 28 patients and 15 healthy controls; ELISA was used to detect the level of IL-9 in the serum. ILC2 of patients and healthy controls was sorted by immunomagnetic beads and cultured separately, and the level of IL-9 in the culture supernatant was measured by ELISA. ILC2 sorted from CLL patients and healthy control-derived peripheral blood mononuclear cells(PBMCs) were co-cultured with the B cell leukemia MEC-1 cells, one group was supplemented with IL-9 antibody and the other group was not. After 72 hours of culture, the ratio of Tregs, programmed death 1 (PD-1), T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT), cytotoxic T lymphocyte antigen 4 (CTLA-4) on Tregs, granzyme B and perforin in CD8+ T cells were measured by flow cytometry, IL-9 level of the culture supernatant was measured by ELISA, the apoptosis of MEC-1 cells was measured by Annexin V-PI. Results Compared with the healthy control group, the levels of ILC2, Tregs and IL-9 in the CLL group increased significantly. The levels of granzyme B and perforin in CD8+ T cells were positively correlated in the peripheral blood of CLL patients. Compared with the healthy control group, IL-9 levels in the supernatant of sorted ILC2 from CLL patients increased. In the anti-IL9 antibody group, the level of PD-1 and TIGIT on Tregs decreased, and the level of granzyme B in CD8+ T cells increased significantly. The level of IL-9 in the anti-IL9 antibody group decreased statistically. And MEC-1 cells showed increased early apoptotic rate in the anti-IL9 antibody group statistically. Conclusion In CLL, ILC2 affects CD8+ T cells and Tregs through IL-9, which weakens the anti-tumor effect of CD8+ T cells, enhances the immunosuppressive effect of Tregs, and plays a role in the occurrence and development of CLL disease.
